Pisano et al. conducted a systemic review that revealed XO inhibitors could reduce the risk of renal failure in patients with CKD with or without gout 25; but no significant improvement in proteinuria and serum creatinine levels was observed compared with the control group. The gene discussed is XDH; the disease is chronic kidney disease.